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following cochlear implantation
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Thomas R. Van De Water and Adrien A. Eshraghi
Department of Otolaryngology, Miller School of Medicine, University of Miami, Miami, FL, USA
Conservation of a patient’s residual hearing and prevention of fibrous tissue/new bone
formation around an electrode array are some of the major challenges in cochlear
implant (CI) surgery. Although it is well-known that fibrotic tissue formation around
the electrode array can interfere with hearing performance in implanted patients, and
that associated intracochlear inflammation can initiate loss of residual hearing, little is
known about the molecular and cellular mechanisms that promote this response in
the cochlea. In vitro studies in neonatal rats and in vivo studies in adult mice were
performed to gain insight into the pro-inflammatory, proliferative, and remodeling phases
of pathological wound healing that occur in the cochlea following an electrode analog
insertion. Resident Schwann cells (SC), macrophages, and fibroblasts had a prominent
role in the inflammatory process in the cochlea. Leukocytes were recruited to the
cochlea following insertion of a nylon filament in adult mice, where contributed to
the inflammatory response. The reparative stages in wound healing are characterized
by persistent neuro-inflammation of spiral ganglion neurons (SGN) and expression of
regenerative monocytes/macrophages in the cochlea. Accordingly, genes involved in
extracellular matrix (ECM) deposition and remodeling were up-regulated in implanted
cochleae. Maturation of scar tissue occurs in the remodeling phase of wound healing
in the cochlea. Similar to other damaged peripheral nerves, M2 macrophages and
de-differentiated SC were observed in damaged cochleae and may play a role in cell
survival and axonal regeneration. In conclusion, the insertion of an electrode analog
into the cochlea is associated with robust early and chronic inflammatory responses
characterized by recruitment of leukocytes and expression of pro-inflammatory cytokines
that promote intracochlear fibrosis and loss of the auditory hair cells (HC) and SGN
important for hearing after CI surgery.
Keywords: neuro-inflammation, fibrosis, pathology, cochlea, cochlear implant, Schwann cells, macrophages,
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Introduction
Cell regeneration (Löwenheim et al., 1999; Stone and Rubel, 2000;
Kawamoto et al., 2003; Levic et al., 2007; Chen et al., 2013;
Mizutari et al., 2013; Shi et al., 2013) and stem cells (Ito et al.,
2001; Li et al., 2003;Martinez-Monedero and Edge, 2007; Koehler
et al., 2013; Bas et al., 2014) are emerging therapies that aim
to restore hearing in patients with deafness. Despite promising
results, these novel therapies will take a long time to reach clinical
application due to concerns regarding both safety and efficacy.
Cochlear implantation is still one of the best options for patients
with unserviceable hearing.
Cochlear implantation can restore hearing perceptions in
patients with significant sensorineural hearing loss (SNHL) by
bypassing the auditory hair cells (HC) and directly stimulating
the spiral ganglion neurons (SGN). Non-traumatic cochlear
implantation can be associated with preservation of auditory HCs
of the apical andmiddle turns of the cochlea, which are important
for low and even mid-frequency residual hearing, respectively.
Significant gains in hearing in quiet and in noise as well as
improvements in music perception are associated with residual
“acoustic” hearing preservation following cochlear implantation
(Mowry et al., 2012). Another important factor associated with
better hearing outcomes following CI surgery is preventing
excessive cochlear fibrosis, because fibrosis in the cochlea can
negatively impact electrode impedance and “electrical” hearing
perception with CIs (Hughes et al., 2001; Choi and Oghalai, 2005;
Jia et al., 2011; Wolfe et al., 2013; Mosca et al., 2014). Although
there have been many triumphs in CI research, long-term
residual hearing preservation and prevention of fibrous tissue
formation around an electrode array are still major challenges in
cochlear implantation (Santa Maria et al., 2013).
Hearing outcomes after CI surgery depend on the health
of residual auditory HCs, SGNs, and the factors that support
their survival. Auditory HCs and their supporting cells within
the organ of Corti (OC) secrete neurotrophic factors that
support and help maintain SGN viability (Santa Maria et al.,
2014). In addition, the health of Schwann cells (SC, glial
cells of the peripheral nervous system) that reside within the
SGN fibers is also an important component of hearing after
implantation. SCs are responsible for myelination of type 1 SGNs,
assuring an insulating sheath around spiral ganglia axons for
rapid propagation of action potentials from the cochlea to the
cochlear nucleus within the central nervous system (Romand
and Romand, 1990). Similar to auditory HCs and supporting
cells of the OC, SCs also cross-communicate with SGNs through
the expression of neurotrophins and their receptors to promote
SGN homeostasis (Hansen et al., 2001). A loss of sensory
auditory HCs and SCs can reduce the number and activity
of afferent SGNs, which are crucial for hearing in cochlear
implantation (Roehm and Hansen, 2005). Therefore, traumatic
cochlear implantations can magnify post-operative electrical-
acoustic hearing impairments through synergistic losses of
auditory HCs and SGNs. The application of “soft” atraumatic
surgical techniques in CI surgery and the development of
electrode arrays designed to reduce friction and trauma in
the cochlea can reduce auditory HC and SGN losses, thereby
improving post-operative “electrical-acoustic” hearing outcomes
(Coco et al., 2007; Bas et al., 2012a; Mowry et al., 2012).
Electrode array insertions into the cochlea can initiate loss of
auditory HCs and SGN fibers through direct mechanical injury
and expression of intracochlear inflammatory cascades that are
detrimental to their survival. Through these mechanisms, an
aberrant wound healing response is activated in the cochlea that
leads to fibrosis. By understanding the linkages between electrode
insertion trauma (EIT), inflammation, and fibrosis formation,
therapeutic strategies can be developed against these signaling
pathways to prevent auditoryHC death, loss of SGNs, and fibrotic
deposition to improve post-implantation hearing outcomes.
Using adult mouse in vivo and neonatal rat in vitro
models of electrode analog insertion trauma (EIT) (Bas et al.,
2012b), the molecular and cellular mechanisms involved in the
inflammatory, proliferative and remodeling phases of wound
healing within the cochlea and their role in fibrosis were
investigated. The early inflammatory response characterized by
inflammatory cell infiltration was studied using the in vitro
model. An in vivo model was used to investigate both early and
late phases of the inflammatory response as well as contributions
of the proliferative and remodeling phases of pathological
wound healing to fibrosis and scar formation after EIT. In
summary, a robust neuro-inflammatory response occurs after
EIT, which leads to impressive amounts of cell proliferation,
tissue remodeling, and fibrosis in the cochlea in vitro and in vivo.
Materials and Methods
Animals
For the in vitro section, 3 or 4 day old (P3–P4) SpragueDawley rat
pups were used (Charles River Laboratories, Wilmington, MA,
USA). For the in vivo studies 1.5–2 month old Balb/c mice of
either sex were used (The Jackson Laboratory, Bar Harbor, ME).
The mice were housed in sterile cages in a Virus Antigen Free
facility from theDivision of Veterinary Resources of University of
Miami and were fed sterilized standard diet and water ad libitum.
In Vitro
P3–P4 rat pups are anesthetized with ice for 15min and
then decapitated. The otic capsules were dissected using a
surgical microscope and placed in cold and sterile phosphate
saline buffer (PBS). Cochleae were randomly assigned to each
experimental group: control (no EIT and no treatment), EIT,
and EIT + dexamethasone (DXM) treatment. To simulate EIT
in experimental cochleae, a 0.2mm diameter monofilament
fishing line (Cajun Line; W.C. Bradley Co., OK, USA) was
introduced three to four times through a small (∼0.3mm
diameter) cochleostomy that was created with a sharpened #5
Dumont forcep next to the round window membrane. With
this technique, a high angle (110–150◦) and depth of insertion
(2mm) into the scala tympani was achieved (Bas et al., 2012b).
All cochleae are then incubated for 10min in PBS. Subsequently,
whole OC with lateral wall tissues were harvested and cultured
in serum-free culture media consisting of Dulbecco’s modified
Eagle’s medium (DMEM, Invitrogen, Carlsbad, CA, USA)
supplemented with glucose (final concentration at 6 g/L), 1% of
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N-1 supplement (Sigma Aldrich, St. Louis, MO, USA), penicillin
G (30 U/mL), and either saline or DXM (20µg/ml, D1756,
Sigma Aldrich). The spleens of the pups were also harvested
and kept in DMEM at 4◦C. Leukocytes were isolated from
spleen at 24 h and incubated in a culture dish for 2 h at 37◦C.
Supernatant was discarded and the adhered cells were collected.
An aliquot of the cells was analyzed by Flow Cytometry (LSR-II,
BD Biosciences, San Jose, CA) to confirm 90–95% enrichment
in the monocytes population. To assess leukocyte recruitment
and invasion into injured cochlear tissues, the monocytes were
labeled with QTracker 655 (Life Technologies, Carlsbad, CA),
re-suspended in PBS containing 2% FBS, incubated for 1 h at
37◦C, and exposed to cochlear tissues (whose media was replaced
for PBS + 2% FBS) prior to acquisition of images. For gene
expression studies, the monocytes were re-suspended in serum
free culture media and placed in inserts for indirect co-culture
with the cochlear tissues. Both monocytes and cochlear tissues
were collected at 72 h after co-culture, washed with cold PBS and
stored in Trizol (Life Technologies, arlsbad, CA) at −80◦C until
further processing.
Imaging and Analysis of Leukocyte Behavior in
the Damaged Cochlea Microenvironment
Four cochlear tissue explants (i.e., OC with lateral wall tissues)
were used for each condition with a total of 3 independent
replicates. Conditions were control, EIT, and EIT + DXM.
Sequential images of each group were taken every 15 s for
20min with a 20× lens in a Zeiss LSM 700 confocal upright
microscope. ImageJ was used to analyze the images. Manual
tracking (Manual Track plugin) was performed for 25–30
random cells in each sample. The trajectory and distance
that the leukocytes traveled were measured. The numbers
of leukocyte-leukocyte and leukocyte-tissue interactions were
counted during this time period and the durations of these
interactions were also documented in a double-blinded manner.
The distance and trajectory of each cell was calculated as follow.
Distance =
√
(Xn − X0)
2 + (Yn − Y0)
2, where (xn, yn) are the
coordinates for the last time point (n) and (x0, y0) are the origin
coordinates. Trajectory =
∑n
0
√(
Xi − X(i−1)
)2
+
(
Yi − Y(i−1)
)2
,
where Xi = X − X0 and Yi = Y − Y0 for each coordinate
and
(
X( i−1) ,Y( i−1)
)
are the coordinates for the previous time
point. For display purposes, the TrackMate plugin was used. For
display purposes, the TrackMate plugin was used. For leukocyte-
leukocyte and leukocyte-cochlear tissue interaction counts and
duration of the interactions, each sequence of images was divided
in 4 quadrants (or regions of interest, 320 × 320µm) and 1–80
cells were analyzed in each region.
Gene Expression Analysis of the Indirect
Co-cultured Leukocytes and Injured Cochlear
Tissues
Six cochlear tissue explants (i.e., OC with lateral wall tissues)
were used in each group and 4 independent replicates were
done. Groups were control, EIT, and EIT + DXM. Leukocytes
were removed from leukocyte-and-cochlear tissue co-cultures
and analyzed separately. RNA was extracted with Trizol reagent
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s
protocol. RNA purity and concentration were determined by
the absorbance at 260 and 280 nm using a Nano Drop ND-
1000 (Thermo Fisher Scientific, Waltham, MA). iScript kit (Bio-
Rad, Hercules, CA, USA) was used to synthesize the cDNA.
Quantitative real-time PCR was performed in duplicate by using
iQ SYBR Green Supermix (Bio-Rad) on a iCycler Real-Time
CFX96 Detection System (Bio-Rad). The mRNA levels were
normalized against β-actin (a housekeeping gene). The primers
were designed based on the cDNA sequences obtained from
Ensembl Genome Browser (http://www.ensembl.org).
The primers used were: Chemokine Ccl2 (ENSRNOT
00000009448, NM031530) forward 5′-TAATGCCCCACTCA
CCTGCT-3′, reverse 5′-AGGTGCTGAAGTCCTTAGG-3′;
Sele, (ENSRNOT00000076757, NM138879) forward 5′-GAGA
TCTACATCCAAAGACC-3′, reverse 5′-CTTTACATTCAACC
ACATGGC-3′; Sell (ENSRNOT00000003733, NM019177)
forward 5′- CAGTGTCAGTATGTGATCC-3′, and reverse
5′-GACATATTGGACTAGGAC-3′; Icam1, (ENSRNOT0000
0028066, NM012967) forward 5′-CTGTGTATTCGTTCC
CAGAGC-3′ and reverse 5′-GATCGAAAGTCCGGAGCT-3′;
Vcam1 (ENSRNOT00000019377, NM012889) forward 5′-
GACATCTACTCATTCCCTAAGG-3′ and reverse 5′-GGA
GGTGTAGACTTGTAGT-3′; Il10 (ENSRNOT00000006246,
NM012854) forward 5′-TAAGGGTTACTTGGGTTGC-3′
and reverse 5′-CACCTTTGTCTTGGAGCTT-3′; Tgfb1 (ENS
RNOT00000028051, NM_021578) forward 5′-CGGACTACTAC
GCCAAAGAA-3′ and reverse 5′-TCAAAAGACAGCCACTC
AGG-3′; Actb (ENSRNOT00000042459, NM031144) forward
5′-CGTTGACATCCGTAAAGACC-3′, and reverse 5′-AGCC
ACCAATCCACACAGAG-3′ (Sigma Aldrich). Real-time PCR
was performed using the following parameters: 3min at 95◦C
followed by 40 cycles of 15 s at 95◦C and 1min at 60◦C. Melting
curves were also performed to ensure primer specificity and
evaluate for any contamination. Relative changes in mRNA
levels of genes were assessed using the 11Ct method and
normalized to the house-keeping gene β-actin (Actb) and then to
the expression levels of the control group.
In Vivo
Twenty adult mice were randomly assigned to each selected time
point and group. The animals were anesthetized with a Ketamine
(40mg/kg)-Xylazine (5mg/kg) cocktail. Buprinorphine
(0.05mg/kg) was administrated at this time and 2 times a
day for 2 more days. The eye blink response to a light touching
of the cornea and a toe pinch withdrawal response was used to
determine the depth of the anesthesia, which was kept a surgical
plane. We also looked at any changes in both rate and depth of
inspirations in the breathing pattern of the anesthetized mice.
The post-auricular hair was shaved and the area cleaned
with iodine. Artificial tears were added to each eye to prevent
corneal dryness. Five microliter of 1% lidocaine was used for local
anesthesia. A post auricular incision was performed behind the
experimental ear and extended ventrally to the rostral neck skin.
The subcutaneous connective tissues were separated to expose
the deep structures. The ear canal, the sternocleidomastoid
muscle and the facial nerve were identified. The bulla that
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encloses the middle and inner ears was visualized below the
facial nerve. A self-retaining retractor was used to maintain
exposure. The soft tissue structures overlying the temporal bone
were removed to expose the bulla. A small hole was opened in
the bulla and ∼2mm of sterile nylon monofilament (∼0.2mm
diameter) was introduced through a puncture in the round
window membrane and left in place. Tissue glue was used to
plug the hole made into the bulla and the skin was sutured
closed with nylon sutures and cleaned once more with topical
iodine. The contralateral ear was used as an internal control.
The animals were returned to clean cages fitted with a water
circulating warming pad and checked periodically during the
post-anesthesia recovery period. The animals were euthanized
with inhaled CO2 at 1, 3, 7, 14, or 30 days after the implantation.
The cochleae were kept either in Trizol at −80◦C for mRNA
processing or in freshly prepared 4% paraformaldehyde at 4◦C
for immunostaining processing.
Genes Involved in Fibrosis
Cochleae from adult mice exposed to unilateral cochlear
implantation for 7 days were utilized. Pooled samples from
five adult mice non-implanted cochleae were compared to five
implanted cochleae; experiments were replicated three times. The
cochleae that were preserved at −80◦C in Trizol (Life Sciences,
Carlsbad, CA) were thawed in a bath of ice and homogenized.
Total RNA was extracted following the manufacturer’s protocol.
The quantity and quality of RNA was measured. RT2 First
Strand Kit for cDNA synthesis and RT2 SYBR Green qPCR
Mastermix with a RT2 Profiler PCR Array for Mouse Fibrosis
genes (all from Qiagen, Valencia, CA, USA) were used in the
gene expression studies. Data analysis of the PCR Array was
performed with Qiagen’s web based software using the 11Ct
method. The raw data was normalized to housekeeping genes
(Actb and Gusb). Paired experiments were run and the average
of the fold change between implanted cochleae and contralateral
unoperated control was calculated.
Immunohistology
Cochleae from mice exposed to unilateral cochlear implantation
for 1, 3, 7, 14 and 30 days were utilized (N = 4 or 5
per condition). The cochleae kept in 4% in paraformaldehyde
were transferred to 10% EDTA buffered in PBS at pH 6 and
kept in gentle rotation for 7 days. The cochleae were washed
in PBS and passed through a sucrose gradient from 5 to
30%. Cochleae were then frozen in O.C.T. compound media
(Tissue-Tek, Sakura Finetek USA, Inc, Torrance, CA, USA)
and cryosections were performed parallel to the central plane
of the modiolus of the cochleae. Slides were washed in PBS
and kept in a blocking-permeabilizating media (normal serum,
1% Triton x-100 in PBS) for 1 h. After this time, samples
were incubated at 4◦C overnight with either of the following
primary antibodies: rabbit anti-Arginase I (sc-20150, Santa Cruz
Biotech, Dallas, TX, USA), rabbit anti-Interleukin 1β pAb (sc-
7884, Santa Cruz Biotech, Dallas, TX, USA) or rabbit anti-
ITGA4 (A0696, Neobiolab, Woburn, MA, USA). The slides
were washed 3 times with PBS and incubated for 90min
at room temperature with anti-F4/80-FITC (ab60343, Abcam,
Cambridge, MA, USA) for Arg1 and IL-1β or Phalloidin-FITC
(Sigma-Aldrich, St Louis, MO, USA), and the secondary antibody
anti-rabbit IgG Alexa 633. After 3 more washes the specimens
were stained with DAPI, washed and cover-slipped with anti-
fade mounting media. The sections were observed under a Zeiss
LSM 700/confocal upright microscope. Images of different areas
of the cochlea were acquired and later constructed. ImageJ
was used to analyze the images, histograms of red and green
channels for each region of interest (i.e., lateral wall, organ of
Corti, spiral ganglion, cochlear nerve, and wound site) were
recorded.
Histological Distribution of the Fibrotic Tissue
Selected slides from cochleae cryosections were stained using a
Masson’s Trichrome Stain Kit (Polysciences, Inc, Warrington,
PA, USA) following the manufacturer’s instructions. Slides
were then dehydrated in alcohol gradient, cleared with Histo-
Clear (National Diagnostics, Charlotte, NC) and mounted with
Cytoseal XYL (Richard-Allan Scientific, Campus Dr, Kalamazoo,
MI). The specimens were observed under a Zeiss Axiovert 200
microscope with a×10 lens and the mosaic images were stitched
together afterwards from individual images.
Statistics
One-Way ANOVA and Tukey’s Multiple Comparison test were
utilized for in vitro studies: leukocyte distance covered, trajectory
of leukocytes, counts of leukocyte-leukocyte and leukocyte-
tissue interactions, and duration of interactions. The same test
was applied for the in vitro gene expression study. Two-Way
ANOVA followed by Bonferroni post-hoc tests were used to
analyze the relative and absolute fluorescence intensities from
the adult cochleae immunolabeling studies (in vivo studies). In
all graphs the results are expressed as mean values ± S.D. In
the study of genes involved in fibrosis in adult mice cochleae,
the results are expressed as mean values ± S.D. Genes from
implanted cochleae that demonstrated differences of ≥2 mean
fold changes over control values were considered up regulated.
Mean fold changes from control values ≤0.5 were considered
down-regulated.
Results
Increased Leukocyte Recruitment and Cell-Cell
Interaction in Damaged Cochlear Tissues
Cell movement analyses: Figure 1 shows the analysis of tracked
leukocytes exposed to EIT cochlear tissue explants. The trajectory
(a, 94.7 ± 2.5, N = 250 cells, p < 0.001) and distance
(b, 14.48 ± 1.8, N = 249 cells, p < 0.001) covered by
these tracked leukocytes were significantly reduced compared
with leukocytes co-cultured with undamaged control cochlear
tissue explants (a, 191.8 ± 8.7, N = 239 cells; distance,
b, 96.9 ± 5.9, N = 249 cells). The behavior of leukocytes
was assessed in EIT cochlear tissue explants following DXM
treatment (20µg/ml), a synthetic steroid known to inhibit
expression of pro-inflammatory cytokines, chemokines, and cell
adhesion molecules in other tissue types. Leukocyte response
in DXM treated EIT cochlear tissue explants was similar
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FIGURE 1 | Analysis of tracked cells for direct leukocyte and cochlear
tissue co-cultures. (A) Leukocyte trajectory and (B) leukocyte distance
covered. Comparison are between EIT-cochlear tissues and undamaged
controls and with EIT pre-treated with Dexamethasone (DXM, 20µg/ml).
N = 239− 250 cells/group, One-Way ANOVA and Tukey’s Multiple
Comparison Test was used for statistical analysis ***p < 0.001.
to responses observed in undamaged control explants and
significantly different from EIT cochlear tissues (DXM treated:
trajectory, a: 178.6 ± 8.0, N = 239 cells, p < 0.001 compared to
EIT; distance, b: 105.2± 4.1, N = 249 cells, p < 0.001 compared
to EIT). Videos of leukocyte recruitment and interaction in the
three different groups of cochlear tissue explants can be viewed
in the supplemental data section (Supplemental Movies 1–6).
Each sequence of images was divided in quadrants or regions
of interest (320 × 320µm). We found a significant increase in
the number of leukocyte-leukocyte (a, 70 ± 3, N = 9 regions
of interest, p < 0.001) and leukocyte- cochlear tissue (b, 9 ±
1, N = 11 regions of interest, p < 0.001) interactions between
the leukocytes co-cultured with the EIT explant group compared
to the undamaged cochlear tissue explants (leukocyte-leukocyte,
a: 18 ± 4, N = 9 regions of interest, and leukocyte-cochlear
tissue, b: 5 ± 1, N = 11 regions of interest) (Figures 2A,B).
DXM treatment did not affect the number of interactions
between leukocytes and leukocyte-cochlear tissue explants, when
compared to the EIT group of explants (DXM treated: leukocyte-
leukocyte, a: 62 ± 6, N = 9 regions of interest, p > 0.05;
leukocyte-cochlear tissue, b: 9 ± 1, N = 11 regions of interest,
p > 0.05 The duration of interactions between leukocytes in
the EIT group of explants was significantly increased compared
to values obtained in the undamaged control group of explants
(458.20± 30.95 EIT vs. 71.76± 12.15 control explants,N = 278,
p < 0.001) (Figure 2C). Interestingly, even though DXM did
not alter the number of cell-cell interactions between leukocytes
and leukocyte-and-cochlear tissue, the time that the leukocytes
remained in contact was significantly shorter than durations
FIGURE 2 | Cell-cell interactions analysis for direct leukocyte and
cochlear tissue co-cultures. (A) Number of leukocyte-leukocyte
interactions in leukocytes and cochlear tissues co-cultures; (B) number of
leukocyte-cochlear cells interactions in co-cultures and (C) time average that
leukocytes interact. Comparisons are between EIT-cochlear tissues and
undamaged controls and with EIT pre-treated with dexamethasone (DXM,
20µg/ml). In upper and middle graphs, the number of cells interacting was
averaged from 9 to 11 quadrants or regions of interest. For the bottom panel,
N = 278 cells/group. One-Way ANOVA and Tukey’s Multiple Comparison Test
was used for statistical analysis ***p < 0.001, ns non-significant p-value.
observed in the EIT group of explants (c, DXM treated: 222.70±
23.53, N = 278).
Cochlear Tissues and Leukocytes Overexpress
Chemokines and Cell Adhesion Molecules in
Response to an Electrode Analog
Insertion-induced Trauma in Vitro
EIT injury in cochlear tissues is associated with increased mRNA
levels for the potent chemokine Ccl2 in both cochlear tissue
(4.76 ± 0.21, N = 4, p < 0.001) and leukocytes that were co-
cultured with EIT cochlear tissues (2.27 ± 0.12, N = 4, p <
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FIGURE 3 | Gene expression studies in vitro. The experiments were
performed in indirect leukocyte and cochlear tissue co-cultures. The top
panel shows the gene expression levels for leukocytes (white), where
(A) Ccl2, (B) Sell, (C) Icam, and (D) Tgfb1. The bottom (gray) panel
shows the gene expression levels in cochlear tissues, i.e., organ of
Corti and lateral wall tissues, where (E) Ccl2, (F) Sele, (G) Vcam, and
(H) Tgfb1. Comparisons are between EIT-cochlear tissues and
undamaged controls and with EIT pre-treated with Dexamethasone
(DXM, 20µg/ml). Six animals per group were included in each set of
experiments and a total of 4 independent experiments were carried out.
N = 4, One-Way ANOVA and Tukey’s Multiple Comparison Test was
used for statistical analysis ***p < 0.001.
0.001), when compared tomRNA levels for this chemokine in the
undamaged control group (Figures 3A,B). A rise in the transcript
levels that encode for the cell adhesionmoleculesVcam1 (34.11±
2.29, N = 4, p < 0.001) and Sele (17.34 ± 0.89, N = 4,
p < 0.001) was observed in EIT cochlear tissues when compared
to the undamaged control explants. Similarly, an increase in
Icam1 (17.31 ± 1.58, N = 4, p < 0.001) and Sell (5.55 ± 0.37,
N = 4, p < 0.001) mRNA levels was observed in the co-cultured
leukocytes from the EIT group of explants, when compared to
uninjured explants. In addition, Tgfb1, a growth factor released
by SCs and macrophages upon nerve injury, was overexpressed
in both cochlear tissues (42.02 ± 8.77, N = 4, p < 0.001) and
leukocytes (14.50 ± 2.46, N = 4, p < 0.001) in the EIT explant
group, when compared to the uninjured control group. DXM
treatment (20µg/ml) of EIT cochlear tissues and leukocytes
demonstrated significant reductions in Ccl2, Vcam1, Sele, Icam1,
Sell, and Tgfb1 gene expression levels when compared to EIT
injured cochlear tissue and leukocytes (p < 0.05; Figure 3).
Fibrosis-related Gene Expression Levels in Vivo
Real-time PCR: Gene expression profiling for the
proliferative/fibrogenic process in cochlear tissue harvested
from adult mice exposed to unilateral cochlear implantation for
7 days was performed (Table 1). In order to maintain consistency
with the literature, genes with fold change = 2 in EIT cochlear
tissue when compared to expression levels of contralateral
un-operated cochleae were considered up-regulated. Gene
expression levels ≤0.5 when compared to control cochleae
were considered down-regulated. Consistent with previous
publications of peripheral nerve injury and our in vitro gene
expression data, there were increased expression levels of of
Th1 (i.e., Il1a and Il1b) and Th-2 (i.e., Il4 and Il13) types of
cytokines in EIT cochlear tissues. The chemokines Ccl3 and
Ccl12 responsible for the recruitment of leukocytes to the
wound site were also up-regulated in implanted cochlear tissues.
Higher levels of mRNA for platelet-derived growth factor beta
polypeptide (Pdgfb), a protein that promotes proliferation,
differentiation, and migration were observed in cochlear tissues
traumatized by the monofilament insertion. Vascular endothelial
growth factor A (Vegfa), which is a member of the PDGF family
and promotes angiogenesis and vascular permeability, was also
up-regulated in implanted tissues. mRNA levels for the integrin
subunits α1 (Itga1), α2 (Itga2), α3 (Itga3), αv (Itgav), and β6
(Itgb6) were higher in EIT cochlear tissues when compared to
contralateral ears, while Itgb3 levels were lower in implanted
cochleae.
Similar to the in vitro study results, Tgfb1 gene expression
levels were also higher in the adult implanted cochleae compared
to the contralateral control cochleae at 7 days. Interestingly,
Tgfb3 and its receptor Tgfbr2, which are associated with scar-
less wound healing were down-regulated in EIT cochlear tissues.
mRNA expression levels for enzymes involved in extracellular
matrix (ECM) remodeling such as Mmp2, Mmp3, Mmp13,
Mmp14, Urokinase-type plasminogen activator (Plau), Serpine1,
Serpinh1, Timp1, and Timp2 were all increased following EIT,
relative to un-implanted cochlear tissues. High gene expression
levels for hepatocyte growth factor (Hgf, a protein involved in
angiogenesis and tissue regeneration) and ECM components
smooth muscle α-2 actin (Acta2), collagen type 1 (Col1a2)
and 3 (Col3a1) were observed in traumatized cochleae when
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TABLE 1 | Gene expression profile of the proliferative/fibrogenic process
at 7 days post-cochlear implantation in adult mice.
Mean S.D. Mean S.D.
fold fold
Mmp3 35.80 10.38 Snai1 1.79 0.27
Ccl12 31.52 7.97 Ltbp1 1.75 0.35
Timp1 17.25 5.25 Il5 1.62 0.17
Col3a1 15.97 8.82 Dcn 1.61 0.31
Ccl3 12.74 4.71 Tnf 1.59 0.19
Col1a2 8.50 2.70 Itgb8 1.56 0.27
Il13 8.32 3.00 Ccr2 1.51 0.14
Il13ra2 6.04 1.41 Edn1 1.42 0.47
Serpine1 5.50 3.19 Stat6 1.42 0.43
Mmp14 5.21 2.93 Stat1 1.38 0.18
Il1a 5.12 0.83 Smad2 1.37 0.13
Fasl 4.95 1.32 Timp3 1.33 0.41
Itgb6 4.93 3.33 Nfkb1 1.31 0.20
Il1b 4.05 0.65 Cebpb 1.30 0.63
Il4 4.05 1.40 Agt 1.28 0.66
Timp2 3.89 0.78 Eng 1.25 0.46
Thbs2 3.75 1.35 Smad6 1.25 0.63
Jun 3.67 0.45 Ccl11 1.20 0.23
Lox 3.40 1.33 Tgif1 1.19 0.13
Mmp13 3.19 1.30 Serpina1a 1.19 0.21
Serpinh1 2.92 1.75 Tgfbr1 1.18 0.21
Hgf 2.79 1.11 Smad4 1.16 0.14
Itga2 2.73 0.55 Plat 1.15 0.18
Plau 2.58 1.39 Cxcr4 1.09 0.25
Ctgf 2.45 0.75 Smad3 1.08 0.28
Itgav 2.38 0.88 Myc 1.02 0.20
Mmp2 2.33 1.13 Akt1 1.00 0.32
Itga3 2.29 1.16 Timp4 0.99 0.21
Vegfa 2.22 0.69 Thbs1 0.97 0.19
Itga1 2.14 0.99 Tgfb2 0.95 0.17
Acta2 2.12 0.81 Egf 0.93 0.27
Grem1 2.11 1.41 Itgb5 0.93 0.35
Tgfb1 2.03 0.28 Pdgfa 0.81 0.11
Pdgfb 2.01 0.95 Sp1 0.81 0.08
Itgb1 1.95 0.25 Smad7 0.79 0.30
Bmp7 1.93 0.54 Ilk 0.71 0.07
Mmp9 1.81 0.51 Mmp8 0.64 0.09
Cav1 1.80 0.32 Mmp1a 0.63 0.18
Ifng 1.79 0.27 Itgb3 0.62 0.06
Il10 1.79 0.27 Bcl2 0.50 0.02
Inhbe 1.79 0.27 Tgfb3 0.50 0.06
Plg 1.79 0.27 Tgfbr2 0.47 0.10
normalized to control cochleae. Lysyl oxidase (Lox, a protein
coding gene that is known to mediate the cross-linking of the
ECM proteins collagen and elastin), thrombospondin-2 (Thbs2;
mediator of cell-cell and cell-matrix interactions), Gremlin-
1 [Grem1, an antagonist of the bone morphogenetic proteins
(BMP)] and Jun (proto-oncogene) were all over-expressed in
cochlear tissues traumatized by EIT, when compared to the
unoperated control group. In injured cochleae, Fas ligand (Fasl;
initiator of the extrinsic pathway of cell death) was upregulated
and Bcl2 (anti-apoptotic protein involved in mitochondrial
cell death) levels were significantly reduced relative to control
cochleae.
Early Expression of Integrin 4α Following an
Electrode Analog Insertion Trauma
Integrin 4α (ITGA4) is a receptor that is expressed after
peripheral nerve injury, binds to fibronectin, and is important
for neuron regeneration and cell-matrix interactions during
leukocyte recruitment. Fluorescence intensities were measured
in cross sections of cochleae at 1, 3, 7, 14, and 30 days after
EIT after immunofluorescence labeling for ITGA4. Relative
fluorescence intensity values were obtained by normalizing
data to contralateral un-operated cochleae of these same areas
(Figures 4–6). There was increased ITGA4 expression at 1
and 3 days post-implantation, which rapidly dropped at 7
days in lateral wall tissues, OC, spiral ganglion, and site of
monofilament insertion. ITGA4 expression either returned to
baseline (lateral wall and OC), decreased (site of monofilament
insertion), or increased (spiral ganglia) 14 days after implantation
(Figures 4, 5).
Cell-cell junctions are comprised of cadherin, catenins, and
filamentous actin (f-actin) cytoskeleton. Together, f-actin and
myosin II form stress fibers, which are contractile bundles
important for cell adhesion; they are abundant in endothelial
cells, epithelial cells, and myofibroblasts. As a result, f-actin
remodeling can affect the integrity of cell-cell junctions and
destabilize the epithelial barrier, rendering leukocytes access to
surrounding tissues. Reorganization of the actin cytoskeleton and
loss of cell-cell adhesions are also seen in epithelial-mesenchymal
transition, a phenomenon that occurs in fibrosis and wound
healing (Haynes et al., 2011). A significant reduction in f-actin
levels in lateral wall, spiral ganglion and cochlear nerve at 3–
7 days in vivo contrasts with an increase on this stress fibers
component in the area where the electrode-analog was placed
(Figures 4, 6).
Macrophages and Schwann Cells Involvement in
Early and Chronic Inflammatory Responses
Glial cells are non-neuronal cells that are important for myelin
formation. They also surround neurons, ground them to the
ECM, supply nutrients to neurons, and can destroy and remove
pathogens in their environment. Macroglia are large glial cells
of the peripheral nervous system that specialize in phagocytosis;
SCs are a type of macroglial cell that provides myelination
to axons in the peripheral nervous system remove cellular
debris through phagocytosis to promote regeneration of nerves
(Haack and Hynes, 2001; Gardiner, 2011). Although they can
be supportive for neuron regeneration, activated SCs assume
many cellular responsibilities, some that are detrimental to
nerves. Following nerve injury, SCs release a number of pro-
inflammatory cytokines (such as IL-1β) that contribute to the
neuro-inflammatory response (Shamash et al., 2002; Tofaris et al.,
2002). Similar to SCs, monocytes also demonstrate cytotoxic and
cell protective properties. Monocytes can also transform into
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FIGURE 4 | Time-course immunofluorescence analysis for integrin 4α
and f-actin levels in different areas of adult mice implanted cochleae.
(A) Lateral wall tissues (see Figure 6, spiral ligament, SL), (B) organ of Corti,
(C) spiral ganglion, (D) cochlear nerve, and (E) wound site. Three to four
specimens for each time point and were analyzed. ImageJ was used to
analyze the images, histograms of red and green channels for each region of
interest i.e., lateral wall, organ of Corti, spiral ganglion, cochlear nerve, and
wound site images were recorded. N = 8 each time point, Two-Way ANOVA
followed by Bonferroni posttests was used to analyze the relative and
absolute fluorescence intensities. ***p < 0.001, **p < 0.01, *p < 0.05 and
+++p < 0.001, ++ p < 0.01, +p < 0.05 represent the p-values for ITGA4
and F-actin, respectively.
FIGURE 5 | Immunofluorescence images for integrin α4 (ITGA4) in red
and cell nuclei in blue. Cross sections corresponding to a contralateral
cochlea (bottom), and cochleae at 1, 3, 7, 14, and 30 days post-implantation.
The sections were observed under a confocal microscope. Mosaic images of
different areas of the cochlea were acquired and later constructed. Three to
four specimens were analyzed for each time point. Scale bars = 100µm.
M1 and M2 tissue macrophages. While M1 macrophages of the
classical pathway secrete pro-inflammatory cytokines (such as
IL-1β), monocytes that are primed by the alternative pathway
(Th-2) or M2 macrophages release anti-inflammatory cytokines
that promote cell survival and regeneration and express Arginase
1 (Arg1) (Martinez et al., 2008; Stout, 2010; Ydens et al., 2012).
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FIGURE 6 | Immunofluorescence images for f-actin in green and cell
nuclei in blue. Cross sections corresponding to a contralateral cochlea
(bottom), and cochleae at 1, 3, 7, 14, and 30 days post-implantation. The
sections were observed under a confocal microscope. Mosaic images of
different areas of the cochlea were acquired and later constructed.
Annotations for the different structures of the cochlea are in the contralateral
photograph. Spiral ligament, SL; organ of Corti, OC; Scala tympanica, ST;
Spiral ganglion, SG. In the implanted cochleae: electrode analog channel,
ECh; an asterisk marks hyperproliferative tissue in the Scala tympanica. Three
to four specimens were analyzed for each time point. Scale bars = 100µm.
Therefore, macrophage and SC activity can be indirectly studied
using markers for IL-1β and Arg1.
Relative fluorescence intensities (Figure 7) for IL-1β (a pro-
inflammatory cytokine, indirect marker used for the classical
activation pathway of M1 macrophages and SCs), Arg1 (indirect
marker for the alternative pathway activated M2 macrophages),
and F4/80 (marker for monocytes, macrophages and microglia)
were calculated and normalized as described in the previous
section. Immunofluorescence images at days 1, 3, 7, 14, and
30 post-implantation are shown for F4/80 (Figure 8), IL-
1β (Figure 9), and Arg1 (Figure 10). Progressive increases in
monocyte/macrophage infiltration (F4/80) and IL-1β production
were seen in the lateral wall tissues over time, reaching maximum
levels at 14 and 30 days post-implantation. In the OC, the IL-1β
levels increased on day 14 and then remained stable until day 30.
Interestingly, monocyte/macrophage infiltration and the levels of
Arg1 showed a biphasic pattern of expression with one peak at 3
days and the second at 14 days. After 1 month post-implantation,
the levels of Arg1 remained higher than IL-1β and the intensity
of F4/80 staining for monocytes/macrophages/microglia was
reduced. Results from the spiral ganglion area and wound site
(area of monofilament insertion) were similar, i.e., Arg1 levels
and monocyte/macrophage /microglia invasion rose rapidly at
1 day post-implantation with maximum levels detected at 7
days post-implantation. In the spiral ganglion, the levels of Arg1
predominated over IL-1β levels, peaking at day 7, indicating
involvement of M2 macrophages. Expression of IL-1β and Arg1
in the wound site (area of electrode insertion) overlapped at
all times, suggesting that both M1 and M2 macrophages are
present. In the cochlear nerve, there is a progressive increase
in monocytes/macrophages infiltration and IL-1β expression,
beginning at post-implantation day 3.
Excessive Deposition of Fibrotic Tissue after an
Electrode Analog Insertion Trauma
Cochleae implanted with a monofilament were processed with
antibodies for α-smooth muscle actin (myofibroblast marker)
and Collagen type 1A 30 days after implantation and compared
to contralateral control cochleae. The fibrous tissue that formed
around the electrode array (O-shaped ring) demonstrated
presence of myofibroblasts and expression of Collagen type 1A,
while unoperated cochleae did not demonstrate any staining for
these markers (Figure 11).
Cochleae from adult mice that received unilateral cochlear
implantation in vivo were harvested 30 days after implantation,
stained with Masson’s trichrome and examined for the presence
of scar tissue (Figure 12). Implanted cochleae demonstrated blue
staining for collagen fibers in the scala tympani (the area of the
monofilament insertion). Sections obtained from contralateral
unoperated cochleae did not demonstrate blue staining for
collagen. The magnitude of the scar thickness can be appreciated
in Figure 12.
Discussion
Cochlear implantation can restore hearing in patients with
significant HL by electrically stimulating the neurons of
SG. Preservation of residual auditory HCs and hearing and
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FIGURE 7 | Time-course immunofluorescence analysis for IL-1β,
Arg1, and presence of macrophages/microglia (F4/80 positive
cells) levels in different areas of the implanted cochleae. (A)
Lateral wall tissues (marked as SL, spiral ligament in the
immunofluorescence images), (B) organ of Corti (OC, see Figure 8),
(C) spiral ganglion (SG), (D) cochlear nerve, and (E) wound site
(asterisk in Figure 8). ImageJ was used to analyze the images,
histograms of red and green channels for each region of interest i.e.,
lateral wall, organ of Corti, spiral ganglion, cochlear nerve, and wound
site images were recorded. N = 8 each time point, Two-Way ANOVA
followed by Bonferroni posttests was used to analyze the relative and
absolute fluorescence intensities. ***p < 0.001, **p < 0.01, *p < 0.05,
+++p < 0.001, and ###p < 0.001, ##p < 0.01 represent the p values
for F4/80, Arg1 and IL-1β, respectively.
FIGURE 8 | Immunofluorescence images for F4/80
(monocytes/macrophages/microglia, green) and nuclei (blue).
Representative micrographs of cross sections correspond to a contralateral
cochlea (bottom), and cochleae at 1, 3, 7, 14, and 30 days post-implantation.
A heavy influx of monocytes/macrophages/microglia can be observed at 3
days in the newly formed tissue en sheathing electrode analog as well as in
the lateral wall, organ of Corti, and to a lessen extend to the spiral ganglion
area. The sections were observed under a confocal microscope. Images of
different areas were acquired and stitched together afterwards. Annotations
for the different structures of the cochlea are in the contralateral photograph.
Spiral ligament, SL; organ of Corti, OC; Scala tympanica, ST; Spiral ganglion,
SG. In the implanted cochleae: electrode analog channel, ECh; an asterisk
marks hyperproliferative tissue in the Scala tympanica. Four to five
specimens were analyzed for each time point. Scale bars = 100µm.
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FIGURE 9 | Immunofluorescence images for interleukin-1β (IL-1β,
red), and nuclei (blue). Representative micrographs of cross
sections correspond to a contralateral cochlea (bottom), and
cochleae at 1, 3, 7, 14, and 30 days post-implantation. A strong
red signal at 7 days post-implantation, especially in the spiral
ganglion area and wound site, reveals a severe neuro-inflammatory
response. The sections were observed under a confocal
microscope. Images of different areas were acquired and stitched
together afterwards. Four to five specimens were analyzed for each
time point. Scale bars = 100µm.
FIGURE 10 | Immunofluorescence images for Arginase I (Arg1, red)
and nuclei (blue). Representative micrographs of cross sections are from a
contralateral cochlea (bottom), and cochleae at 1, 3, 7, 14, and 30 days
post-implantation. Note that red blood cells are accumulated over the organ
of Corti area, these cells are auto-fluorescent due to hemoglobin
fluorescence. An increase in Arg1 levels at 7 days post- implantation,
especially in the spiral ganglion area and wound site, indicates healing
process. The sections were observed under a confocal microscope. Images
of different areas were acquired and stitched together afterwards. Four to five
specimens were analyzed for each time point. Scale bars = 100µm.
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FIGURE 11 | Immunofluorescence images for the myofibroblast marker
α-smooth muscle actin (α-SMA, red), Collagen type 1A (COL1A1,
green) and nuclei (blue). Representative micrographs of cross sections
correspond to a contralateral cochlea and a cochlea implanted for 1 month.
Cells from the fibrotic tissue enclosing the electrode analog stain positive for
α-SMA and COL1A1, asterisks indicate the presence of fibrotic tissue. The
sections were observed under a confocal microscope. Images of different
areas were acquired and stitched together afterwards. Scale bars = 100µm.
FIGURE 12 | Masson’s trichrome staining for the presence of scar
tissue. Representative micrographs of section of a contralateral non-implanted
cochleae on the left, section of implanted cochlea on the right. Collagen fibers
stained blue, nuclei stained black and cytoplasm and erythrocytes stained red.
Images of different areas were acquired and stitched together afterwards. Four
contralateral and four implanted cochleae were used. Scale bar = 100µm.
reducing injury to SGNs during and after implantation can
improve hearing outcomes with electrical-acoustic stimulation
(Mowry et al., 2012). However, CI surgery initiates a strong
inflammatory response in the cochlea that can promote loss
of SGNs and remaining auditory HCs that are crucial for
hearing perception. In addition, the inflammatory response
that is produced following cochlear implantation promotes
fibrotic tissue deposition around the electrode array, which can
also impair electrode impedance and post-implantation hearing
outcomes (Hughes et al., 2001; Choi and Oghalai, 2005; Jia et al.,
2011; Wolfe et al., 2013; Mosca et al., 2014). Removal of cochlear
fibrosis is nearly impossible without causing significant trauma
in the inner ear that can promote more inflammation and fibrotic
deposition. In cases of CI device failure and need for explantation
and re-implantation, intracochlear osteoneogenesis and excessive
fibrosis make CI electrode insertion extremely challenging and
sometimes impossible (Côté et al., 2007). Descriptions of the
trauma caused by electrode insertion and associated fibrosis and
new bone formation in human temporal bones can be found
in the literature (Eshraghi et al., 2003; Fayad et al., 2009). The
basal portion of the cochlea is most affected by EIT induced
fibrosis and osteoneogenesis. The wound healing response that
leads to fibrosis and new bone formation has not been well
characterized following cochlear implantation. By understanding
the pathophysiologic mechanisms of EIT and wound healing in
the cochlea, different therapeutic strategies can be investigated to
modulate fibrosis in the inner ear and prevent loss of SGNs and
residual auditory HCs following cochlear implantation.
Wound healing in peripheral nerve demonstrates similarities
to cutaneous tissues (Mutsaers et al., 1997; Velnar et al., 2009;
Stout, 2010; Ydens et al., 2012). In injured peripheral nerve,
a strong inflammatory and proliferative response occurs at the
site of injury and is followed by a late remodeling phase. SCs
of injured nerve rapidly release a number of pro-inflammatory
cytokines, chemokines, and cell adhesionmolecules that promote
recruitment of inflammatory cells to the wounded area (Shamash
et al., 2002; Tofaris et al., 2002). Monocytes are recruited to
the injured nerve, where they transform into M1 and M2
macrophages. M1 macrophages have debride bacteria, damaged
tissues, and cellular debris and release reactive radicals and pro-
inflammatory cytokines (such as TNF-α and IL-1β) that are toxic
to surrounding tissue during the acute and chronic inflammation.
M2 macrophages secrete anti-inflammatory cytokines and
factors important for nerve regeneration and tissue remodeling
(Martinez et al., 2008; Stout, 2010). Both resident activated
macrophages and SCs contribute to myelin down-regulation
and phagocytosis (Romand and Romand, 1990). Phagocytosis,
however, can be a double-edged sword in peripheral nerve injury.
Although removal of apoptotic cells and debris is thought to be
part of a homeostatic mechanism to prevent or delay cell death
signals from spreading, phagocytosis of myelin and damaged
SGNs can adversely affect the propagation of action potentials
critical to auditory processing (Hurley et al., 2007).
Peripheral nerve injury can also lead to inflammation and
injury more proximally. Similar to macrophages (Stout, 2010)
and microglia from the central nervous system, astrocytes (the
most abundant macroglial cell of the central nervous system)
can exhibit polarized phenotypes induced by either classical
or alternative activation in response to peripheral nerve injury
(Reichert et al., 1994; de Waele et al., 1996). Reactive astrocytes
have been found within the cochlear nucleus following a
labyrinthectomy (Jang et al., 2013).
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These classical activated macro-glia cells show neurotoxic
effects and express Il1b, Inos, Tnfa, and Cxcl10 genes. M1
macrophages and SCs of the classical pathway express pro-
inflammatory cytokines such as IL-1β and M2 macrophages
and astrocytes (activated with IL-4 and IL-13) of the alternative
pathway express other regenerative and anti-apoptotic factors
such as Il10, Arg1, Mrc1, Il1ra, Fizz1, and Ym1. (Perry and
Gordon, 1988; Haack and Hynes, 2001; Vogelezang et al., 2001;
Martinez et al., 2008; Stout, 2010; Ydens et al., 2012).
Subsequently, a proliferative phase predominates after the
initial inflammatory phase of wound healing in nerve injury.
Fibroblasts and activated macrophages produce large amounts of
matrix proteins (fibrins and collagens) creating an extracellular
matrix (ECM) that acts as a network where cell-cell (through
cadherins and different cell adhesion molecules) and cell-matrix
(through integrins) interactions promote migration, growth, and
cellular differentiation (e.g., myofibroblast formation) (de Waele
et al., 1996; Stout, 2010; Ydens et al., 2012). Fibronectin (i.e.,
a component of the ECM) is rapidly upregulated upon injury
to peripheral nerves either by fibroblasts or endothelial cells.
De-differentiated SCs in injured nerve express integrin α4β1,
a receptor protein that binds fibronectin and promotes axonal
regeneration and SC proliferation (Jessen andMirsky, 1999, 2002;
Haack and Hynes, 2001; Vogelezang et al., 2001; Gardiner, 2011).
Although integrin α4β plays a role in nerve regeneration, the
expression of α4 integrin can also mediate influx of immune cells
to the injured nerve through VCAM1 binding, propagating the
inflammatory response (Rose et al., 2002). After proliferation,
remodeling occurs at the injured nerve, inflammation and
angiogenesis declines, and scarring matures.
The wound healing process that occurs in the cochlea
following EIT parallels descriptions in peripheral nerve injury.
A robust inflammatory response occurs following EIT. Injured
cochlear tissues express a number of pro-inflammatory factors
and chemoattractants such as chemokine Ccl2, cell adhesion
molecules Sele and Vcam1, and growth factor Tgfb1 3 days after
EIT in vitro (Figure 3). Cultured monocytes migrate to the site
of cochlear injury and express other pro-inflammatory cytokines,
chemokines, and factors at 3 days in vitro (Ccl2, Sell, Icam1,
and Tgfb1; Figures 1–3). In our hands, DXM did not affect the
number of interactions between leukocytes and leukocyte-tissue
cells, however a decrease in the duration of these interactions was
observed. Similarly, other authors (Mancuso et al., 1995; Tailor
et al., 1997) have already reported that DXM affects selectively
the leucocyte emigration process, but not the rolling or adhesion
processes in response to chemoattractants onto themicrovascular
tissues of the rat mesentery. Therefore, a reduction in the
time of interaction may affect the leukocytes trans-endothelial
emigration. Particularly in the OC, spiral ganglia, and site of EIT
in vivo, monocytes transform into M1 macrophages that secrete
other inflammatory factors (such as IL-1ß) and M2 macrophages
that express regenerative and anti-apoptotic factors (such as
Arg1; Figures 6–8). Increased Arg1 expression in the spiral
ganglia may in part be due to infiltrating M2 or SCs activated by
the alternative pathway, promoting nerve regeneration (Reichert
et al., 1994; Martinez et al., 2008; Stout, 2010; Ydens et al., 2012;
Jang et al., 2013). The lateral wall, OC, spiral ganglia, and site of
EIT all express integrin 4α (receptors for fibronectin important
nerve regeneration and cell-matrix interactions) during the early
wound healing process (Figures 4, 5) that persists in the OC,
spiral ganglia, and wound bed 30 days after implantation in vivo.
Fibroblasts and differentiated myofibroblasts proliferate in the
cochlea after EIT injury and new collagen is deposited in the
wound bed around the electrode analog in vivo (Figure 9) (Van
De Water et al., 2013). F-actin was up regulated in the area of
a monofilament insertion in mouse cochleae in vitro, suggesting
there is reorganization of the actin skeleton and remodeling of
the ECM (Figures 4, 6). Scar forms and matures around the
electrode array in the cochlea during the remodeling phase of
wound healing (Figure 12). Macrophage activity still persists at
high levels in the wound bed (site of EIT) at 30 days in vivo,
suggesting an atypical chronic inflammatory response and a
possible immune response against a foreign body (the electrode
analog).
Increased gene expression for leukocyte chemoattractants
(Ccl3 and Ccl12), pro-angiogenesis factors (Vegfa, Hgf ), integrin
subunits important for collagen deposition (Itga1, Itga2, Itga3),
enzymes responsible for ECM remodeling (Mmp2, Mmp3,
Mmp13, Mmp14, Plau, Serpine1, Serpinh1, Timp1, Timp2) (La
Fleur et al., 1996), components of the ECM (Acta2, Col1a2,
Col3a1), and mediators of ECM cross-linking and interactions
(Lox, Thbs2) were also demonstrated in cochlear tissue following
EIT in vivo, supporting histologic findings of wound healing in
the cochlea (Table 1). Tgfb3 and its receptor Tgfbr2, which are
associated with scar-less wound healing, were down-regulated in
EIT cochlear tissues, representing a possible therapeutic target for
prevention of fibrotic scar in future studies.
In summary, cochlear implantation promotes a wound
healing response in the cochlea characterized by an inflammatory
phase (i.e., expression of pro-inflammatory cytokines,
chemokines, and chemoattractants, leukocyte infiltration, and
macrophage activation), a proliferative phase (i.e., angiogenesis,
fibroblast and differentiated myofibroblast proliferation, collagen
deposition, synthesis of ECM, and scar formation), and a
remodeling phase (i.e., turnover of the ECM and maturation
of the scar). How trauma and inflammation from EIT can
initiate loss of auditory HCs and SGNs is well-described in
the literature (Roehm and Hansen, 2005; Bas et al., 2012b).
However, the molecular and cellular mechanisms involved
in the proliferative and remodeling phases following EIT are
not entirely known. The results of this study confirm key
events in the inflammatory process following EIT and offer a
detailed description of the proliferative and remodeling cascades
of wound healing in the cochlea. A chronic inflammatory
response characterized by macrophage activity is evidenced
long after initial cochlear trauma and likely represents a foreign
body reaction to the electrode analog (nylon filament) and a
source of pro-inflammatory factors that can be detrimental
to remaining HCs and viable SGNs long-term. Furthermore,
fibrotic deposition in the cochlea following EIT was also
confirmed and associated signaling cascades were depicted
in this study. By understanding these pro-inflammatory,
proliferative, and remodeling phases of wound healing in the
cochlea following EIT, therapeutic strategies can be developed
and tested to mitigate losses of auditory HCs and SGNs from a
robust inflammatory response, reduce fibrosis that can interfere
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with electrode impedance, and alter chronic inflammatory
changes in the inner ear from a foreign body reaction in efforts
to improve residual hearing preservation, electrical-acoustic
hearing outcomes, and quality of life after cochlear implantation.
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Supplemental Movie 1 | Cell tracking of leukocytes co-cultured with
undamaged control group of organ of Corti and lateral wall tissues. Four
cochlear tissue explants (i.e., organ of Corti and lateral wall tissues) were used,
with a total of 3 independent replicates. Sequential images of each group were
taken every 15 s for 20min with a 20× lens in a Zeiss LSM 700/ confocal upright
microscope. ImageJ with Trackmate plugin was used to make the movies. The
detected cells are included in a magenta circle and the line color codes are in
function of the velocity for that particular cell. A rainbow color code displays dark
blue lines for slow moving cells and red for fast moving cells (3.2µm/s). Scale bar
= 100µm.
Supplemental Movie 2 | Raw sequential images for Supplemental Movie 1.
Supplemental Movie 3 | Cell tracking of leukocytes co-cultured with EIT
group of organ of Corti and lateral wall tissues. Four cochlear tissue explants
were used, with a total of 3 independent replicates. Sequential images of each
group were taken every 15 s for 20min with a 20× lens in a Zeiss LSM 700/
confocal upright microscope. ImageJ with Trackmate plugin was used to make
the movies. The detected cells are included in a magenta circle and the line color
codes are in function of the velocity for that particular cell. A rainbow color code
displays dark blue lines for slow moving cells and red for fast moving cells
(3.2µm/s). Scale bar = 100µm.
Supplemental Movie 4 | Raw sequential images for Supplemental Movie 3.
Supplemental Movie 5 | Cell tracking of leukocytes co-cultured with EIT
pre-treated with dexamethasone (20µg/ml) group of organ of Corti and
lateral wall tissues. Four cochlear tissue explants were used, with a total of 3
independent replicates. Sequential images of each group were taken every 15 s
for 20min with a 20× lens in a Zeiss LSM 700/ confocal upright microscope.
ImageJ with Trackmate plugin was used to make the movies. The detected cells
are included in a magenta circle and the line color codes are in function of the
velocity for that particular cell. A rainbow color code displays dark blue lines for
slow moving cells and red for fast moving cells (3.2µm/s). Scale bar = 100µm.
Supplemental Movie 6 | Raw sequential images for Supplemental Movie 5.
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